v3.24.2.u1
Condensed Consolidated Statements of Stockholders' Equity - USD ($)
$ in Thousands
Total
Class A Common Stock
Common stock
Common stock
Class A Common Stock
Common stock
Class B Common Stock
Additional Paid-in Capital
Accumulated Deficit
Accumulated Other Comprehensive Income (Loss)
Noncontrolling Interests
Increase (Decrease) in Stockholders' Equity [Roll Forward]                  
Stockholders' Equity, beginning balance $ 824,725     $ 0 $ 0 $ 1,497,373 $ (725,648) $ (705) $ 53,705
Stockholders' Equity, beginning balance (in shares) at Jan. 31, 2023       94,655,000 56,489,000        
Increase (Decrease) in Stockholders' Equity [Roll Forward]                  
Conversion of stock (in shares)       7,358,000 (7,358,000)        
Issuance of common stock related to vested exercised stock options (in shares)         2,060,000        
Issuance of common stock related to vested exercised stock options 17,933         17,933      
Issuance of common stock under employee stock purchase plan (in shares)       247,000          
Issuance of common stock under employee stock purchase plan 7,751         7,751      
Repurchases, net of early exercised stock options (in shares)         (13,000)        
Issuance of common stock related to RSUs vested (in shares)       1,038,000          
Charitable donation of common stock (in shares)   133,389 134,000            
Charitable donation of common stock 5,350 $ 5,300       5,350      
Vesting of early exercised stock options 809         809      
Stock-based compensation expense 78,698         81,359     (2,661)
Change in noncontrolling interest ownership           (503)     503
Other comprehensive income (loss) 81             2,487 (2,406)
Net income (loss) (104,107)           (102,549)   (1,558)
Stockholders' Equity, ending balance (in shares) at Jul. 31, 2023       103,432,000 51,178,000        
Stockholders' Equity, ending balance at Jul. 31, 2023 831,240     $ 0 $ 0 1,610,072 (828,197) 1,782 47,583
Increase (Decrease) in Stockholders' Equity [Roll Forward]                  
Stockholders' Equity, beginning balance 815,601     $ 0 $ 0 1,542,603 (778,117) 1,003 50,112
Stockholders' Equity, beginning balance (in shares) at Apr. 30, 2023       96,240,000 56,453,000        
Increase (Decrease) in Stockholders' Equity [Roll Forward]                  
Conversion of stock (in shares)       6,213,000 (6,213,000)        
Issuance of common stock related to vested exercised stock options (in shares)         940,000        
Issuance of common stock related to vested exercised stock options 10,320         10,320      
Issuance of common stock under employee stock purchase plan (in shares)       247,000          
Issuance of common stock under employee stock purchase plan 7,751         7,751      
Repurchases, net of early exercised stock options (in shares)         (2,000)        
Issuance of common stock related to RSUs vested (in shares)       679,000          
Charitable donation of common stock (in shares)   52,647 53,000            
Charitable donation of common stock 2,675 $ 2,700       2,675      
Vesting of early exercised stock options 292         292      
Stock-based compensation expense 46,368         46,555     (187)
Change in noncontrolling interest ownership           (124)     124
Other comprehensive income (loss) (559)             779 (1,338)
Net income (loss) (51,208)           (50,080)   (1,128)
Stockholders' Equity, ending balance (in shares) at Jul. 31, 2023       103,432,000 51,178,000        
Stockholders' Equity, ending balance at Jul. 31, 2023 831,240     $ 0 $ 0 1,610,072 (828,197) 1,782 47,583
Increase (Decrease) in Stockholders' Equity [Roll Forward]                  
Stockholders' Equity, beginning balance 831,240     0 0 1,610,072 (828,197) 1,782 47,583
Stockholders' Equity, beginning balance $ 617,934 [1]     $ 0 $ 0 1,718,661 (1,149,822) 2,335 46,760
Stockholders' Equity, beginning balance (in shares) at Jan. 31, 2024       114,670,000 42,887,000        
Increase (Decrease) in Stockholders' Equity [Roll Forward]                  
Conversion of stock (in shares)       19,855,000 (19,855,000)        
Issuance of common stock related to vested exercised stock options (in shares) 931,000       931,000        
Issuance of common stock related to vested exercised stock options $ 10,074         10,074      
Issuance of common stock under employee stock purchase plan (in shares)       252,000          
Issuance of common stock under employee stock purchase plan 7,932         7,932      
Issuance of common stock related to RSUs vested (in shares)       1,565,000          
Charitable donation of common stock (in shares)   120,241   120,000          
Charitable donation of common stock 5,914 $ 5,900       5,914      
Vesting of early exercised stock options 189         189      
Stock-based compensation expense 91,221         91,425     (204)
Change in noncontrolling interest ownership           (409)     409
Other comprehensive income (loss) (2,647)             (1,765) (882)
Net income (loss) (42,613)           (41,695)   (918)
Stockholders' Equity, ending balance (in shares) at Jul. 31, 2024       136,462,000 23,963,000        
Stockholders' Equity, ending balance at Jul. 31, 2024 688,004 [1]     $ 0 $ 0 1,833,786 (1,191,517) 570 45,165
Increase (Decrease) in Stockholders' Equity [Roll Forward]                  
Stockholders' Equity, beginning balance 614,358     $ 0 $ 0 1,768,947 (1,204,466) 3,360 46,517
Stockholders' Equity, beginning balance (in shares) at Apr. 30, 2024       132,670,000 26,212,000        
Increase (Decrease) in Stockholders' Equity [Roll Forward]                  
Conversion of stock (in shares)       2,619,000 (2,619,000)        
Issuance of common stock related to vested exercised stock options (in shares)         370,000        
Issuance of common stock related to vested exercised stock options 4,981         4,981      
Issuance of common stock under employee stock purchase plan (in shares)       252,000          
Issuance of common stock under employee stock purchase plan 7,932         7,932      
Issuance of common stock related to RSUs vested (in shares)       854,000          
Charitable donation of common stock (in shares)   67,015 67,000            
Charitable donation of common stock 2,957 $ 2,900       2,957      
Vesting of early exercised stock options 91         91      
Stock-based compensation expense 48,969         48,877     92
Change in noncontrolling interest ownership           1     (1)
Other comprehensive income (loss) (3,558)             (2,790) (768)
Net income (loss) 12,274           12,949   (675)
Stockholders' Equity, ending balance (in shares) at Jul. 31, 2024       136,462,000 23,963,000        
Stockholders' Equity, ending balance at Jul. 31, 2024 688,004 [1]     $ 0 $ 0 1,833,786 (1,191,517) 570 45,165
Increase (Decrease) in Stockholders' Equity [Roll Forward]                  
Stockholders' Equity, beginning balance $ 688,004 [1]     $ 0 $ 0 $ 1,833,786 $ (1,191,517) $ 570 $ 45,165
[1]
(1) As of July 31, 2024 and January 31, 2024, the condensed consolidated balance sheet includes assets of the consolidated variable interest entity, GitLab Information Technology (Hubei) Co., LTD (“JiHu”), of $45.0 million and $47.6 million, respectively, and liabilities of $6.5 million and $6.1 million, respectively. The assets of JiHu can be used only to settle obligations of JiHu and creditors of JiHu do not have recourse against the general credit of the Company. Refer to “Note 11. Joint Venture and Equity Method Investment” for further discussion.